FACIALS & SKIN · TREND CHECK
Exosome and salmon DNA facials.
What's actually in the vial?
They sound like the future: tiny cell messengers and fish DNA that tell your skin to act younger. The vials are pretty, the prices range from drugstore to $825, and the before-and-after videos are everywhere. Here is what the FDA, the newest reviews and the dermatologists quoted in the press actually say, in plain words, with the questions that protect your face before anyone opens a vial.

Short answer: Exosome and PDRN (“salmon DNA” or “salmon sperm”) facials are built on interesting science, but the cosmetic evidence is still early and small. The FDA says there are no FDA-approved exosome products, and that microneedling devices are not approved to deliver serums, drugs or other products into the skin. PDRN has a real track record in wound healing, not yet in beauty facials, and people with fish allergies are advised to avoid it. The common mistake is treating a trendy label as proof. The fix is simple: ask what is in the vial, where it came from, how it gets into your skin and who is legally allowed to do that, and put your money first into the basics that are proven.
The scroll that sells the vial
It usually starts at night. You are scrolling, half-awake, and a video shows a frosted vial, a microneedling pen and a face that looks lit from inside. The caption says “exosomes” or “salmon DNA.” The comments say “where?” and “how much?” By morning you have three tabs open: a $24 serum, a $258 serum, and a spa offering an exosome add-on to microneedling.
That gap in price is the first clue. NBC News Select's exosome roundup (updated September 10, 2026) listed products from about $19 to $825, some made with plant-derived ingredients, some described as human-derived, some lab-derived. Its PDRN roundup (August 28, 2025) listed salmon-DNA serums, masks and eye patches mostly between about $18 and $52. Same buzzword, wildly different things in the bottle. Before you decide whether it is worth it, it helps to know what the words mean.
Exosomes and PDRN, in one minute
- Exosomes are tiny, naturally occurring vesicles that cells release to carry proteins, lipids and genetic material such as microRNA to other cells. In skin care, the word can mean very different sources: human cells (for example stem-cell or platelet cultures), animal cells, plants, or lab-made versions. A dermatologist interviewed in a February 2026 press piece put it simply: not all exosomes are created equal, because they don't carry the same instructions.
- PDRN (polydeoxyribonucleotide) is a mixture of DNA fragments, most often purified from salmon or trout sperm cells, which is where the “salmon sperm facial” nickname comes from. PN (polynucleotides) are related, typically longer chains. They are used as topicals, as injectable “skin boosters” abroad, and with microneedling.
Both are pitched as “regenerative”: signals that might calm inflammation and nudge repair. That is a reasonable research question. It is not yet a proven cosmetic result.
What the FDA actually says
Three statements from U.S. regulators shape this whole trend:
- No approved exosome products. In a public safety alert dated December 9, 2019, the FDA said clinics across the country were offering exosome products, warned about unsubstantiated claims, reported “serious adverse events” in patients in Nebraska treated with unapproved products marketed as containing exosomes, and stated: “There are currently no FDA-approved exosome products.” Exosomes used to treat disease are regulated as drugs and biological products. A January 2025 review in the Journal of Drugs in Dermatology repeats that no exosome product has FDA approval.
- Microneedling devices are not approved to push products in. The FDA's microneedling pages (content current as of October 15, 2025) say cleared devices are authorized to improve the appearance of facial acne scars, facial wrinkles and abdominal scars in adults 22 and older, but they “are not approved for delivery of cosmetics, topical medications”, vitamin solutions, drugs or blood products such as PRP. The FDA adds that it “has not cleared any microneedling devices for use with another product” and that the risks of these combinations “are not known.”
- Cosmetic is not the same as proven. A serum sold as a cosmetic does not need FDA approval before it reaches the shelf, and it is not allowed to claim to treat disease. So a cosmetic label can say “exosome” or “PDRN” without anyone having shown it does what the video implies.
None of this means every product is dangerous. It means the burden of proof sits with the seller, and you are allowed to ask for it.
What the research shows so far
Exosomes
The most useful recent summary is a 2026 systematic review in the Journal of Cosmetic Dermatology by Dhaliwal and colleagues, reported by Dermatology Times on April 29, 2026. The authors searched PubMed, Embase and Scopus through June 2025 and found 8 studies covering 171 patients who had microneedling combined with exosomes, for hair loss, skin aging, melasma, enlarged pores, acne and acne scars. Early signals were described as promising and side effects as short-lived (redness, swelling, tingling, burning). But the limits are the headline: sample sizes were “uniformly small,” follow-up never went past six months, most studies were case series or pilots, the exosome source and preparation varied, and the regulatory status of the products was undisclosed in every relevant study.
The January 2025 Journal of Drugs in Dermatology review (Haykal and colleagues) reached a similar place: genuine potential, but “inconsistent isolation methods, source variability” and a need for clinical trials on long-term safety and effectiveness. In other words, two vials both labeled “exosome” may not contain comparable things, and no one can yet tell you the right dose.
PDRN and polynucleotides
PDRN has the longer history. A 2025 review in Applied Sciences (Park and colleagues, 175 studies reviewed) notes that PDRN drugs were approved in Italy in 1994 for wound and ulcer healing, and describes a randomized trial in 216 people with diabetic foot ulcers in which 37.3% of PDRN patients had complete closure at 8 weeks versus 18.9% on placebo. That is meaningful medical evidence. For cosmetic use, the review describes smaller studies, including a 27-person split-face trial against hyaluronic acid filler, and says there is still no firm consensus on what fragment size even counts as PDRN. Worth knowing: several of its authors list an affiliation with a biotech company.
The dermatologists NBC News Select interviewed in August 2025 drew the same line: there is real science showing PDRN can support wound healing, but most of that data comes from medical use such as burns and ulcers, not beauty facials, and PDRN is not FDA-approved in the U.S. One cosmetic chemist told the outlet that most topicals contain roughly 0.5% to 1.5% PDRN, and an aesthetician noted the large molecule won't penetrate deeply on its own.
Hype vs. evidence at a glance
| The claim | What the sources support | What to ask |
|---|---|---|
| “FDA-approved exosomes” | There are no FDA-approved exosome products (FDA, 2019; JDD review, 2025). | Approved for what, by whom? Can I see the document? |
| “Regrows collagen like stem cells” | Early, small studies; no large randomized trials; follow-up up to six months (J Cosmet Dermatol review, 2026). | Which study, how many people, compared with what? |
| “Human exosomes work better than plant ones” | No head-to-head evidence cited in the sources we found; sources and preparations vary widely. | What cell source is it, and how was it tested for safety? |
| “Salmon DNA heals skin” | Good wound-healing data in medical settings; cosmetic data are smaller (Applied Sciences review, 2025). | Is this a cosmetic topical or a medical product? What concentration? |
| “Microneedling drives it in safely” | FDA: devices are not approved to deliver products into skin; combination risks are not known (2025). | Who performs it, under what license, with a new sterile cartridge? |
The seven mistakes we see in this trend
- Treating the label as the ingredient. “Exosome” on the box can mean a human-derived lab product, a plant extract or little more than a marketing word, and the reviews above say sources and preparations vary widely. Read the ingredient list, not the front of the box.
- Assuming “natural” means low-risk. PDRN comes from fish. Dermatologists quoted by NBC advise people with fish allergies to avoid all forms, including topicals.
- Letting a serum ride in on a needle without asking. A cream on intact skin and the same liquid pushed through microchannels are different exposures. The FDA says it has not reviewed the safety of combining microneedling with other products.
- Not asking who is holding the pen. California's Board of Barbering and Cosmetology (industry bulletin, August 7, 2023) lists derma rolling or microneedling, injections and prescription products among services that may be considered invasive or the practice of medicine for its licensees, and its rules prohibit piercing the skin beyond the epidermis.
- Skipping the cartridge question. The FDA tells consumers to ask how a device is cleaned between patients and whether a new needle cartridge is used for every person and every session, because reuse can cause or spread infection.
- Paying premium prices for a promise. A $258 or $825 serum has not been shown to outperform proven basics. Spend there only after sunscreen, a barrier-friendly moisturizer and, if suited to you, a retinoid are already in place.
- Trying it during pregnancy or breastfeeding without asking. A dermatologist quoted by NBC advised against exosome use during pregnancy or breastfeeding, and none of the studies above were designed to answer that safety question. Ask your OB or dermatologist first, and see our pregnancy skin care ingredient guide.
Seven questions to ask before anything touches your face
- What exactly is in this vial, and can I see the full ingredient list or product insert?
- Where do the exosomes or DNA come from: human cells, animals, fish, plants or a lab?
- Is it sold as a cosmetic or as a medical product, and what is its regulatory status in the U.S.?
- Will it go on intact skin, or into skin through microneedling or injection?
- If the skin is penetrated, who is performing it, under what license, and is a physician involved?
- Is the device FDA-cleared, and will you open a new sterile cartridge in front of me?
- What happens if I react, and who do I call after hours?
A good provider welcomes these questions. If the answers are vague or the tone turns into pressure (“the price is only good today”), that tells you something too.
Who should skip it, or ask a doctor first
- Anyone with a fish or seafood allergy (PDRN and PN products).
- People who are pregnant or breastfeeding.
- Anyone with an active infection, open acne lesions, eczema flare, cold sore or broken skin in the area. The FDA lists cold sore flare-ups and infection among possible microneedling effects.
- People with a history of keloids, an autoimmune condition, or who take medicines that affect healing or bleeding: ask your doctor before any skin-penetrating treatment.
- Anyone recently on isotretinoin or using strong prescription retinoids: tell the provider and follow your prescriber's advice.
When to see a clinician
After any treatment, mild redness, tightness and a little peeling for a day or two are common. The FDA lists bleeding, bruising, redness, itching and peeling among microneedling effects, and stinging or itching when products are applied, dark or light spots, cold sore flare-ups, swollen lymph nodes and infection as less common ones. Contact a licensed medical professional promptly for redness that keeps spreading, warmth, swelling, pus, fever, hives, lip or eye swelling, or bumps that appear weeks later. For trouble breathing or throat swelling, call 911. You can report a problem with an FDA-regulated product through FDA MedWatch.
What to try instead (or first)
If what you want is the glow in the video, the least glamorous steps still do most of the work:
- Daily broad-spectrum sunscreen. Our sunscreen application guide covers how much and how often.
- A barrier-friendly moisturizer with ingredients such as ceramides; see our ceramide guide.
- A retinoid, introduced slowly, if your skin and your doctor agree; start with our retinol vs. retinoid guide.
- Professional facials for cleansing, hydration and a calmer-feeling face, chosen for your skin rather than a trend. Not sure which? Our which facial should I book guide walks through it.
- A board-certified dermatologist for acne scars, deep wrinkles or pigment that won't budge, where FDA-cleared procedures exist.
If you still want to try a PDRN or exosome topical on intact skin, patch test first, introduce one new product at a time, and judge it over a few weeks rather than one selfie. Our patch testing guide explains how, and its limits.
A note for Santa Ana and Orange County
Two local things matter here. First, our fall is dry and bright: Santa Ana wind days can drop humidity sharply, and the sun stays strong well into November, so any freshly treated or needled skin needs extra protection from wind, dryness and UV. Our Santa Ana winds skin guide has the wind-week routine. Second, Orange County has no shortage of places offering the newest add-on, from Irvine and Costa Mesa to Little Saigon in Westminster and Garden Grove. The questions above travel with you; ask them in any language, at any price point.
What the good version looks like
Picture this instead of the 2 a.m. checkout. You sit down with someone who looks at your skin in daylight, asks what you are already using, and tells you plainly what the evidence supports. You leave with a short routine you can actually keep, a facial plan that matches your skin, and a clear answer about whether any trend product belongs in it. Six weeks later your skin feels calmer and looks fresher, you know exactly what made the difference, and you didn't pay for a mystery vial to find out.
How this works at Enclave
Enclave Beauty in Santa Ana starts with a free 45-minute skin consultation: we look at your skin, your routine and your goals before suggesting anything. Current starting prices on our services menu include the Signature Relax Facial from $85, the Dermaplaning Facial from $110 and the Acne & Detox Facial from $135. If you are weighing an infusion-style service, including our Meso Cocktail Therapy (from $250), the same seven questions apply, and you are welcome to ask them at your consultation. Prices can change; the facials page always shows today's menu.
If you have a fish allergy, are pregnant, or have reacted to a treatment before, tell us first. If something you describe needs a doctor rather than a facial, we will say so.
Frequently asked questions
Do exosome facials actually work?
The honest answer is: not proven yet. A 2026 systematic review in the Journal of Cosmetic Dermatology (Dhaliwal et al., as reported by Dermatology Times on April 29, 2026) found only 8 studies with 171 patients on microneedling with exosomes. Sample sizes were uniformly small, follow-up never exceeded six months, and the regulatory status of the exosome products was not disclosed in any of them. A January 2025 review in the Journal of Drugs in Dermatology called the potential real but named inconsistent isolation methods and source variability as major unsolved problems.
Are exosomes FDA-approved for skin?
No. The FDA stated in a December 9, 2019 public safety alert that there are currently no FDA-approved exosome products, after serious adverse events in Nebraska patients treated with unapproved products marketed as containing exosomes. The January 2025 Journal of Drugs in Dermatology review and NBC News Select (updated September 10, 2026) both report that no exosome product is FDA-approved, including for cosmetic use. A topical serum sold as a cosmetic does not need FDA approval before sale, which is not the same as being proven to work.
What is PDRN, and is the salmon sperm facial real?
PDRN (polydeoxyribonucleotide) is a mix of DNA fragments usually extracted from salmon or trout sperm cells. It has a real medical history: a 2025 review in Applied Sciences notes PDRN drugs were approved in Italy in 1994 for wound healing, and a randomized trial in 216 people with diabetic foot ulcers found complete closure in 37.3% with PDRN vs 18.9% with placebo at 8 weeks. Most of that evidence comes from wounds, not cosmetic facials, and PDRN is not FDA-approved in the U.S. for skin rejuvenation.
Can I use a PDRN serum if I have a fish allergy?
Dermatologists interviewed by NBC News Select (August 28, 2025) advised that anyone with a fish allergy should avoid applying any form of PDRN, including topicals, and noted a small risk of allergic reaction in people with fish sensitivities. If you have a fish or seafood allergy, skip salmon-derived products and ask your doctor before trying any substitute.
Is it safe to microneedle exosomes or PDRN into the skin?
The FDA says microneedling devices are not approved for delivering cosmetics, topical medications, vitamin solutions, drugs or blood products such as PRP into the skin, and that it has not cleared any microneedling device for use with another product (October 15, 2025). The risks of that combination are not known. In California, the Board of Barbering and Cosmetology lists microneedling among services that may be considered invasive or the practice of medicine for its licensees, so ask who is performing it and under what license.
What should I try instead if I want glow and firmness?
Start with what has decades of evidence: daily broad-spectrum sunscreen, a gentle cleanser, a moisturizer that supports the skin barrier, and a retinoid introduced slowly if your skin tolerates it. Professional facials can help skin look and feel fresher. For deeper concerns such as acne scars or wrinkles, see a board-certified dermatologist about FDA-cleared options.
Sources and evidence note
- U.S. Food and Drug Administration — Public Safety Alert Due to Marketing of Unapproved Stem Cell and Exosome Products (posted December 9, 2019; no FDA-approved exosome products; serious adverse events in Nebraska patients)
- FDA — Microneedling Devices: Getting to the Point on Benefits, Risks and Safety (content current as of October 15, 2025; no devices cleared for use with another product; risks; cartridge questions)
- FDA — Microneedling Devices (content current as of October 15, 2025; cleared uses; not approved for delivery of cosmetics, drugs or PRP; combination risks not known)
- California Board of Barbering and Cosmetology — Industry Bulletin: Skin Care Machines/Devices (August 7, 2023; microneedling, injections and prescription products listed as possibly invasive or the practice of medicine)
- Dermatology Times — Microneedling With Exosomes Shows Early Promise Across Multiple Skin Conditions, Systematic Review Finds (April 29, 2026), reporting Dhaliwal NK, Moothathamby T, Sokhal BS, Gkini MA. The use of microneedling with exosomes in dermatology: a systematic review. J Cosmet Dermatol. 2026;25(4):e70881 (DOI 10.1111/jocd.70881)
- Haykal D, Wyles S, Garibyan L, Cartier H, Gold M. Exosomes in Cosmetic Dermatology: A Review of Benefits and Challenges. J Drugs Dermatol. 2025;24(1):12-18 (DOI 10.36849/JDD.8872)
- Park S, Baek S, Shin HJ, et al. Polydeoxyribonucleotides as Emerging Therapeutics for Skin Diseases. Applied Sciences. 2025;15(19):10437 (published September 26, 2025; DOI 10.3390/app151910437)
- NBC News Select — Salmon sperm facials? What dermatologists want you to know before trying the buzzy skin care trend (August 28, 2025; PDRN definition, evidence from medical use, fish-allergy caution, product prices)
- NBC News Select — Exosomes in skin care: do they actually work? (updated September 10, 2026; no exosome product FDA-approved for cosmetic use; dermatologist cautions; product prices)
- U.S. Dermatology Partners — Do Exosomes Live Up To Their Anti-Aging Claims? (February 24, 2026; press excerpt; exosomes vary by source and cargo)
- Enclave Beauty — Services (facial starting prices checked November 8, 2026; prices may vary)
Evidence note: The exosome evidence summarized here comes from small, short studies; the 2026 systematic review (8 studies, 171 patients) is reported through Dermatology Times because we could not open the full paper. The 2025 PDRN review is a narrative review, not a systematic one, and some of its authors list a biotech-company affiliation; its strongest data are from wound healing, not cosmetic facials. Dermatologist statements are paraphrased from press interviews and are opinions, not trial results. Product prices are those listed by NBC News Select on the dates shown and are not recommendations. Some pages could not be opened by our research tools (an FDA consumer page on regenerative medicine products, two PubMed Central reviews and PubMed search pages); we used the FDA's safety alert, the FDA microneedling pages, the published reviews and reputable press instead, and did not use archive, cache or mirror copies. We found no reliable figure for how often reactions happen, so we do not state one.
Medical disclaimer: This article is educational and is not medical advice, diagnosis or treatment. Enclave Beauty services do not replace care from a licensed medical professional.